Clinical Research of West Florida- Corporate

Clearwater, Florida 33765

1 studies enrolling now · 7 studies all time

What they study most

Active Cutaneous Lupus Erythematosus, Crohn's Disease, Lupus Erythematosus, Systemic, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE)

Studies at this site

• An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Enrolling by invitation
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) — Completed
• Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease — Stopped early
• A Phase II Study of M2951 in SLE — Stopped early
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) — Stopped early
• Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus — Stopped early